When extracellular glucose and glutamine are abundant, cancer cells synthesize lipids, nucleic acids and non- essential amino acids from these precursors. However, when a cancer's growth exceeds its vascular supply, the cancer cells must adapt to a lower availability of these nutrients as well as oxygen. This past year, we discovered a novel mechanism by which some cancer cells adapt to metabolic stress. Although glutamine- dependent citrate production can support de novo lipid synthesis in hypoxic cells, metabolic tracing studies uncovered that up to 50% of lipids used for phospholipid biosynthesis in hypoxic cells came from exogenous sources. We were able to determine that hypoxia-induced macropinocytosis facilitates the uptake and incorporation of unsaturated phospholipids to maintain effective unsaturated fatty acid levels under conditions in which stearoyl CoA desaturase is inhibited by oxygen limitation. Follow-up studies have demonstrated that cellular scavenging of extracellular macromolecules is induced in an Ras-dependent fashion in transformed cells and provides a potent mechanism by which Ras-transformed cells can adapt to metabolic stress in their environment. Based on these recent discoveries, 3 Specific Aims are proposed for this competitive renewal: 1) Determine if the ability of Ras-induced lipid scavenging to support cell growth depends on the availability of extracellular unsaturated fatty acids. 2) Define the molecular basis by which Ras induces the uptake of unsaturated fatty acids. 3) Examine the role of autophagy components in Ras-mediated lipid uptake. Through these studies we hope to elucidate an important and novel mechanism by which cancer cells adapt to metabolic stress and determine whether this pathway can be therapeutically exploited.
How cancer cells maintain the synthesis and integrity of their phospholipid membranes when deprived of the fatty acid precursors, glucose and glutamine, is poorly understood. In this proposal, we propose experiments to determine the role of the oncogene Ras in directing the uptake of lipids from the extracellular environment and the ability of this process to overcome the need for glucose and/or glutamine to support phospholipid biosynthesis.
|Zhang, Ji; Pavlova, Natalya N; Thompson, Craig B (2017) Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J 36:1302-1315|
|Davis, Jeremy L; Langan, Russell C; Panageas, Katherine S et al. (2017) Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma. Ann Surg Oncol 24:1989-1996|
|Xie, Hong; Simon, M Celeste (2017) Oxygen availability and metabolic reprogramming in cancer. J Biol Chem 292:16825-16832|
|Rozpedek, W; Nowak, A; Pytel, D et al. (2017) Molecular Basis of Human Diseases and Targeted Therapy Based on Small-Molecule Inhibitors of ER Stress-Induced Signaling Pathways. Curr Mol Med 17:118-132|
|Gannon, Patrick J; Akay-Espinoza, Cagla; Yee, Alan C et al. (2017) HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via ?-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. Am J Pathol 187:91-109|
|Ricca, Jacob; Turkekul, Mesruh; Barlas, Afsar et al. (2017) Validation of Anti-Mouse PDL-1 Goat Polyclonal Antibody Staining with Mouse PDL-1 In Situ Hybridization on Adjacent Sections of Cell Pellets and Mouse Tumors. Methods Mol Biol 1554:253-262|
|Sands, Stephen; Ladas, Elena J; Kelly, Kara M et al. (2017) Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer. Support Care Cancer 25:701-708|
|Gade, Terence P F; Tucker, Elizabeth; Nakazawa, Michael S et al. (2017) Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma. Radiology 283:702-710|
|Palm, Wilhelm; Thompson, Craig B (2017) Nutrient acquisition strategies of mammalian cells. Nature 546:234-242|
|Pytel, Dariusz; Gao, Yan; Mackiewicz, Katarzyna et al. (2016) PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma. PLoS Genet 12:e1006518|
Showing the most recent 10 out of 113 publications